AXA SA (0HAR)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 42.53 |
|---|---|
| 52-week range | 36.55 – 45.67 |
| Return, 1 month / 3 months | −2.9% / −6.3% |
| Return, 1 year / 3 years | +13.9% / +82.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 18.6% |
| Worst drawdown (1 year) | -9.8% |
| Average daily value traded | 33.19M EUR |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AXA SA is a French insurance group based in Paris. It provides life and non-life insurance, health cover and savings products to individual customers and businesses, and it also runs asset management operations. Its customers include private individuals, small companies and large corporate clients across Europe, Asia and the Americas. The group sells protection and retirement products through agents, brokers and direct channels, and manages investment funds for institutional and retail investors.
AXA SA trades under the code 0HAR on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AXA SA (0HAR) trades on the London Stock Exchange in UK. It last closed at EUR 42.53 on 27 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 353 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.9% and over the last three months it fell 6.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.6% | ||
| From 52-week high | -6.7% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.3% | ||
| 6-month return | 10.5% | ||
| 12-month return, skipping the last month | 17.3% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 18.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -9.8% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 33.19M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −2.9% |
| 3 months | −6.3% |
| 6 months | +10.5% |
| 1 year | +13.9% |
| 3 years | +82.1% |
| 5 years | +135.0% |
Signals
| 50-day / 200-day average | 43.21 / 40.64 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | EUR 2.3200 |
| 2 May 2025 | EUR 2.1500 |
| 30 Apr 2024 | EUR 1.9800 |
| 5 May 2023 | EUR 1.7000 |
| 6 May 2022 | EUR 1.5400 |
| 7 May 2021 | EUR 1.4300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.